Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.
To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Glucaric acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Basora M et al. | Optimizing preoperative haemoglobin with intravenous iron. | 2013 | Br J Anaesth | pmid:23404979 |
Devasenapathy N et al. | Is intravenous iron sucrose the treatment of choice for pregnant anemic women? | 2013 | J. Obstet. Gynaecol. Res. | pmid:23167561 |
Wilson PD et al. | An analysis of the health service efficiency and patient experience with two different intravenous iron preparations in a UK anaemia clinic. | 2013 | J Med Econ | pmid:22989163 |
Douard V et al. | Excessive fructose intake causes 1,25-(OH)(2)D(3)-dependent inhibition of intestinal and renal calcium transport in growing rats. | 2013 | Am. J. Physiol. Endocrinol. Metab. | pmid:23571713 |
Yang Z et al. | Parasitic nematode-induced modulation of body weight and associated metabolic dysfunction in mouse models of obesity. | 2013 | Infect. Immun. | pmid:23509143 |
Potthoff SA and Münch HG | [Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease]. | 2013 | Dtsch. Med. Wochenschr. | pmid:23737117 |
Janus N et al. | Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC survey. | 2013 | Support Care Cancer | pmid:23715817 |
Giger M and Achermann R | [Iron substitution in outpatients in Switzerland: Increase of costs associated with intravenous administration]. | 2013 | Z Evid Fortbild Qual Gesundhwes | pmid:23916272 |
Ferumoxytol: an intravenous iron, riskier than iron sucrose. | 2013 | Prescrire Int | pmid:24171212 | |
Rowlands M et al. | The effect of intravenous iron on postoperative transfusion requirements in hip fracture patients: study protocol for a randomized controlled trial. | 2013 | Trials | pmid:24015990 |